PHENO THERAPEUTICS LIMITED

Company number SC612347

Date	Type	Description	View / Download
10 Mar 2022	AP01	Appointment of Dr Jane Kathleen Relton Rhodes as a director on 1 March 2022	(2 pages)
10 Mar 2022	TM01	Termination of appointment of Jonathan David Moore as a director on 2 March 2022	(1 page)
15 Nov 2021	SH01	Statement of capital following an allotment of shares on 9 November 2021 GBP 800	(3 pages)
08 Nov 2021	CS01	Confirmation statement made on 30 October 2021 with no updates	(3 pages)
03 Jun 2021	AA	Unaudited abridged accounts made up to 31 December 2020	(11 pages)
16 Nov 2020	CS01	Confirmation statement made on 30 October 2020 with updates	(5 pages)
16 Nov 2020	PSC08	Notification of a person with significant control statement	(2 pages)
30 Oct 2020	PSC07	Cessation of Neil Oliver Carragher as a person with significant control on 25 March 2019	(1 page)
13 Mar 2020	AA	Unaudited abridged accounts made up to 31 December 2019	(12 pages)
09 Dec 2019	AP01	Appointment of Enrique Millan as a director on 18 November 2019	(2 pages)
09 Dec 2019	AP01	Appointment of Dr Timothy John Roy Harris as a director on 3 December 2019	(2 pages)
28 Nov 2019	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association	(65 pages)
22 Nov 2019	SH01	Statement of capital following an allotment of shares on 19 November 2019 GBP 550.00	(4 pages)
31 Oct 2019	CS01	Confirmation statement made on 30 October 2019 with updates	(5 pages)
20 Jun 2019	SH01	Statement of capital following an allotment of shares on 7 June 2019 GBP 500.00	(4 pages)
15 May 2019	AP01	Appointment of Dr Rajesh Bhikhu Parekh as a director on 28 March 2019	(3 pages)
17 Apr 2019	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of Memorandum and/or Articles of Association	(63 pages)
12 Apr 2019	RESOLUTIONS	Resolutions RES13 ‐ Share sub-division,provisions of article 3.3 be disapplied two directors so permitted to participate in the decision making process and in accordance with section 569 rights of pre-emption in respect to issue are disapplied 22/03/2019 RES10 ‐ Resolution of allotment of securities	(1 page)
10 Apr 2019	SH01	Statement of capital following an allotment of shares on 28 March 2019 GBP 400.00	(4 pages)
10 Apr 2019	AP01	Appointment of Professor Siddharthan Chandran as a director on 28 March 2019	(2 pages)
02 Apr 2019	SH02	Sub-division of shares on 22 March 2019	(4 pages)
01 Apr 2019	SH01	Statement of capital following an allotment of shares on 25 March 2019 GBP 258.00	(4 pages)
01 Apr 2019	AA01	Current accounting period extended from 31 October 2019 to 31 December 2019	(3 pages)
27 Mar 2019	TM01	Termination of appointment of Neil Oliver Carragher as a director on 22 March 2019	(1 page)
20 Mar 2019	AP01	Appointment of Dr Jonathan David Moore as a director on 15 March 2019	(2 pages)